Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-34,page-paged-34,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive

CLIENT NEWS

 

 

  • Abivax Receives First Phase 2b Ulcerative Colitis Clinical Trial Authorization, Provides Update on Progress of ABX464 Clinical Development Plan in Inflammatory Diseases
    www.abivax.com
  • Biom’up reports 2018 full-year results and provides a business update
    www.biomup.com
  • Molecular Health präsentiert bei anstehenden Kongressen zu Herausforderungen der digitalisierten Medizin
    www.molecularhealth.com
  • Allergy Therapeutics plc: Regulatory and Trading Update
    www.allergytherapeutics.com
  • Notice of Annual General Meeting
    www.motifbio.com
  • Motif Bio Announces Appointment of Andrew Powell to Board of Directors
    www.motifbio.com
  • Expedeon Reports Financial Results for Fiscal Year 2018 – Financial Guidance Met
    www.expedeon.com
  • Biom’up granted FDA IDE approval for HEMOSNOWTM
    www.biomup.com
  • Ergomed’s PrimeVigilance awarded 2019 Queen’s Award for Enterprise
    www.ergomedplc.com
  • CENTOGENE Appoints AI Industry Leader Dr. Carsten Ullrich as Director of Artificial Intelligence
    www.centogene.com